Prasadani, Y. G. M.
Jayasinghe, L.
Illeperuma, R. P.
Kodithuwakku, S. P.
Jayasinghe, R. D. http://orcid.org/0000-0002-8054-4301
Article History
Received: 6 August 2022
Accepted: 19 March 2024
First Online: 13 April 2024
Declarations
:
: The authors report no declarations of interest.
: The YD-10B cells used in the current study were originally established at the Oral Cancer Research Institute, Department of Oral Pathology, Yonsei University College of Dentistry, Seoul, Korea, in the year 2005 and are commercially available in the Korean Cell Line Bank. Hereby we would like to declare that the current study used already established commercial cancer cell lines for the in vitro studies. No primary human or animal cells or tissues were used in the present study. Therefore, the authors have not obtained any ethical clearance for the use of commercial cell lines.